A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
PHASE2
The study is a randomized, double blind, placebo-controlled, dose response,...
A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses
PHASE2
A clinical study to evaluate the efficacy and safety of once daily oral dos...
Status
Recruiting
Location
University Clinical Hospital Mostar, Clinic for Infectious Diseases